Deena M.A. Gendoo

Cited by

	All	Since 2018
Citations	1482	1219
h-index	17	14
i10-index	21	17

280

140

210

20112012201320142015201620172018201920202021202220235 7 7 12 15 83 122 169 221 270 265 267 25

Public access

View all

27 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Benjamin Haibe-KainsScientist (Principal Investigator), Princess Margaret Cancer Centre, University Health NetworkVerified email at uhnresearch.ca
Levi WaldronCity University of New York School of Public HealthVerified email at sph.cuny.edu
Paul M. HarrisonProfessor of Biology, McGill UniversityVerified email at mcgill.ca
Anna GoldenbergScientist, SickKids Research Institute; Assistant Professor Department of Computer Science, University of TorontoVerified email at utoronto.ca
Joel ParkerUniversity of North Carolina at Chapel HillVerified email at email.unc.edu
Mathieu Lupien, Ph.D.Senior Scientist/Professor, Princess Margaret Cancer CentreVerified email at uhnresearch.ca
Andrew H. BeckCo-Founder and CEO at PathAIVerified email at PathAI.com
Markus S. SchröderETH ZürichVerified email at biol.ethz.ch
Heather SelbyStanford UniversityVerified email at stanford.edu
Hugo AertsDirector AI in Medicine (AIM) @ Harvard-MGB | Professor @ MaastrichtUVerified email at dfci.harvard.edu
Patrick GrossmannPh.D. Candidate conducting research at Harvard Medical School, Dana-Farber Cancer Institute, BWHVerified email at jimmy.harvard.edu
Eldad ZacksenhausProfessor of Medicine, University of TorontoVerified email at utoronto.ca
Sepehr EhsaniUniversity College LondonVerified email at ucl.ac.uk
Gary BaderProfessor of Molecular Genetics and Computer Science, The Donnelly Centre, University of TorontoVerified email at utoronto.ca
Ruth IsserlinDonnelly Centre, University of TorontoVerified email at utoronto.ca
Robert CasteloAssociate Professor, Universitat Pompeu Fabra, COSTNET CA15109Verified email at upf.edu
David Gomez-CabreroAssoc. Professor KAUST. Head of the Translational Bioinformatics Unit, Navarrabiomed.Verified email at kaust.edu.sa
Aedin CulhaneUniversity of Limerick School of MedicineVerified email at ul.ie
Sean DavisUniversity of ColoradoVerified email at cuanschutz.edu
Kasper D. HansenDepartment of Biostatistics, Johns Hopkins UniversityVerified email at jhsph.edu

Deena M.A. Gendoo

Associate Professor in Computational Biology, University of Birmingham

Verified email at bham.ac.uk - Homepage

Bioinformatics Computational Biology Cancer Biomedicine Disease Models


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer DMA Gendoo, N Ratanasirigulchai, MS Schröder, L Paré, JS Parker, ... Bioinformatics 32 (7), 1097-1099, 2016	252	2016
PharmacoGx: an R package for analysis of large pharmacogenomic datasets P Smirnov, Z Safikhani, N El-Hachem, D Wang, A She, C Olsen, ... Bioinformatics 32 (8), 1244-1246, 2016	214	2016
CD73 is associated with poor prognosis in high-grade serous ovarian cancer M Turcotte, K Spring, S Pommey, G Chouinard, I Cousineau, J George, ... Cancer research 75 (21), 4494-4503, 2015	186	2015
Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors J Torchia, B Golbourn, S Feng, KC Ho, P Sin-Chan, A Vasiljevic, ... Cancer cell 30 (6), 891-908, 2016	184	2016
The molecular basis of breast cancer pathological phenotypes YJ Heng, SC Lester, GMK Tse, RE Factor, KH Allison, LC Collins, ... The Journal of pathology 241 (3), 375-391, 2017	96	2017
Medulloblastoma subgroups remain stable across primary and metastatic compartments X Wang, AM Dubuc, V Ramaswamy, S Mack, DMA Gendoo, M Remke, ... Acta neuropathologica 129, 449-457, 2015	84	2015
Consensus on molecular subtypes of high-grade serous ovarian carcinoma GM Chen, L Kannan, L Geistlinger, V Kofia, Z Safikhani, DMA Gendoo, ... Clinical Cancer Research 24 (20), 5037-5047, 2018	72	2018
Public data and open source tools for multi-assay genomic investigation of disease L Kannan, M Ramos, A Re, N El-Hachem, Z Safikhani, DMA Gendoo, ... Briefings in bioinformatics 17 (4), 603-615, 2016	56	2016
Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancer DMA Gendoo, RE Denroche, A Zhang, N Radulovich, GH Jang, M Lemire, ... PLoS computational biology 15 (1), e1006596, 2019	49	2019
Integrative cancer pharmacogenomics to infer large-scale drug taxonomy N El-Hachem, DMA Gendoo, LS Ghoraie, Z Safikhani, P Smirnov, ... Cancer research 77 (11), 3057-3069, 2017	36	2017
A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling DY Wang, DMA Gendoo, Y Ben-David, JR Woodgett, E Zacksenhaus Breast cancer research 21, 1-13, 2019	32	2019
Discordant and chameleon sequences: their distribution and implications for amyloidogenicity DMA Gendoo, PM Harrison Protein Science 20 (3), 567-579, 2011	30	2011
PrionHome: a database of prions and other sequences relevant to prion phenomena D Harbi, M Parthiban, DMA Gendoo, S Ehsani, M Kumar, G Schmitt-Ulms, ... PloS one 7 (2), e31785, 2012	28	2012
MetaGxData: clinically annotated breast, ovarian and pancreatic cancer datasets and their use in generating a multi-cancer gene signature DMA Gendoo, M Zon, V Sandhu, VSK Manem, N Ratanasirigulchai, ... Scientific Reports 9 (1), 8770, 2019	25	2019
The first small-molecule inhibitors of members of the ribonuclease E family L Kime, HA Vincent, D Gendoo, SS Jourdan, CWG Fishwick, ... Scientific reports 5 (1), 1-8, 2015	24	2015
Administration of hypoxia-activated prodrug evofosfamide after conventional adjuvant therapy enhances therapeutic outcome and targets cancer-initiating cells in preclinical … J Haynes, TD McKee, A Haller, Y Wang, C Leung, DMA Gendoo, ... Clinical Cancer Research 24 (9), 2116-2127, 2018	20	2018
Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy PED Chung, DMA Gendoo, R Ghanbari-Azarnier, JC Liu, Z Jiang, J Tsui, ... Nature communications 11 (1), 1825, 2020	19	2020
The landscape of the prion protein's structural response to mutation revealed by principal component analysis of multiple NMR ensembles DMA Gendoo, PM Harrison Public Library of Science 8 (8), e1002646, 2012	13	2012
Origins and evolution of the HET-s prion-forming protein: searching for other amyloid-forming solenoids DMA Gendoo, PM Harrison PloS one 6 (11), e27342, 2011	13	2011
Personalized diagnosis of medulloblastoma subtypes across patients and model systems DMA Gendoo, P Smirnov, M Lupien, B Haibe-Kains Genomics 106 (2), 96-106, 2015	11	2015

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors